WINDSOR JAMES BRIAN 4
4 · TFF Pharmaceuticals, Inc. · Filed Dec 3, 2019
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
- Award
Stock Options (Right to Buy)
2019-11-29+3,623→ 139,429 totalExercise: $5.00Exp: 2029-10-29→ Common Stock (3,623 underlying)
Footnotes (1)
- [F1]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.